Strategies to Regulate the Degradation and Clearance of Mesoporous Silica Nanoparticles: A Review
DOI: https://doi.org/10.2147/ijn.s451919
IF: 7.033
2024-06-14
International Journal of Nanomedicine
Abstract:Yuelin Zhang, Xue Lin, Xinxin Chen, Weixiang Fang, Kailing Yu, Wenting Gu, Yinghui Wei, Hangsheng Zheng, Jigang Piao, Fanzhu Li School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, 310053, People's Republic of China Correspondence: Fanzhu Li; Ji-Gang Piao, Email ; Mesoporous silica nanoparticles (MSNs) have attracted extensive attention as drug delivery systems because of their unique meso-structural features (high specific surface area, large pore volume, and tunable pore structure), easily modified surface, high drug-loading capacity, and sustained-release profiles. However, the enduring and non-specific enrichment of MSNs in healthy tissues may lead to toxicity due to their slow degradability and hinder their clinical application. The emergence of degradable MSNs provided a solution to this problem. The understanding of strategies to regulate degradation and clearance of these MSNs for promoting clinical trials and expanding their biological applications is essential. Here, a diverse variety of degradable MSNs regarding considerations of physiochemical properties and doping strategies of degradation, the biodistribution of MSNs in vivo, internal clearance mechanism, and adjusting physical parameters of clearance are highlighted. Finally, an overview of these degradable and clearable MSNs strategies for biosafety is provided along with an outlook of the encountered challenges. Keywords: mesoporous silica nanoparticles, degradation, clearance, biodistribution, strategies Graphical MSNs have emerged as a prominent nanomaterial with growing interest, primarily due to their excellent biocompatibility, tunable pore size, large surface area, and abundant surface ease of functionalization. Their unique properties have positioned them as a significant focus of research and development as nanocarriers in drug delivery. 1–12 However, many studies have reported that slow biodegradability of MSNs could lead to severe particle bioaccumulation, potentially resulting in biosafety problems. 13–16 Generally, the degradation process of MSNs took several days, and the excretion of MSNs took several weeks from the body. 17,18 Therefore, improving the degradation of MSNs for facilitating in vivo studies and clinical trials has become an urgent necessity. Moreover, the requirements of the US Food and Drug Administration (FDA), agents injected into the human body, especially diagnostic ones, must be completely cleared within a reasonable period after achieving the purpose. 19 Systematic evaluations of the degradation behavior and clearance of MSNs in vivo are critical for the achievement of clinical translation and expansion of disease therapeutic applications. 20,21 In view of the extensive research on the degradation and clearance of MSNs. 22–29 This paper will systematically overview the strategies to regulate degradation and clearance of MSNs, with highlights on degradation behavior about organic doping and metal doping, and clearance mechanisms and adjusting physical parameters for clearance. We believe that this review can provide readers with more information on the optimal method to achieve degradation of MSNs and better understand the mechanism of clearance. The degradation of MSNs is a hydrolytic dissolution process, which occurs by the nucleophilic interaction between hydroxyl groups in aqueous media and non-bridged oxygen on MSNs surface, leading to the leach of dissoluble silicic acid. 5 Croissant et al summarized the mechanism of MSNs degradation in an aqueous medium which is divided into three steps: (1) hydration, water molecules are adsorbed to the siloxane skeleton, (2) hydrolysis, siloxane is hydrolyzed to silanol, and (3) ion-exchange, hydroxyl anion nucleophilic attacks, eventually forming silicic acid. 28 In recent years, in addition to regulating the degradation of MSNs by adjusting the physical and chemical properties, studies have also focused on improving the biodegradability of MSNs by reconstructing the silica skeleton, such as constructing organic-inorganic hybrid structures (Si-O-R), or introducing metal ions or metal oxides for doping. Among them, the organic group R has a certain protective effect on silica, making the Si-O-Si skeleton more stable, and using reducible and degradable organics for doping can effectively improve the degradability of MSNs. 30–35 The degradation rate of MSNs depends on two categories of parameters: (i) the particle characteristics (surface area, particle size, pore size, morphology, condensation degree, hydrophilicity /hydrophobicity, surface functional groups, etc.) and (ii) the degradation medium characteristics (protein presence or absence, concentration, etc.). 28 Kuroda et al provided findings on the degradat -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology